S100P and neoplasm: In conclusion, S100P is only expressed in malignant tissues that result in EMT by activating MAPK/ERK1/2 and S100P accumulation that initiates NF-κB activation and AP-1–dependent oncogenic mi-RNA activation, which altogether enhanced tumor migration and invasion.